Arch Biopartners Inc. (TSXV:ARCH)
Canada flag Canada · Delayed Price · Currency is CAD
0.7400
+0.0100 (1.37%)
Mar 12, 2026, 1:09 PM EST

Arch Biopartners Statistics

Total Valuation

TSXV:ARCH has a market cap or net worth of CAD 47.42 million. The enterprise value is 50.03 million.

Market Cap 47.42M
Enterprise Value 50.03M

Important Dates

The next estimated earnings date is Friday, May 29, 2026.

Earnings Date May 29, 2026
Ex-Dividend Date n/a

Share Statistics

Current Share Class 66.93M
Shares Outstanding n/a
Shares Change (YoY) +2.96%
Shares Change (QoQ) +0.91%
Owned by Insiders (%) 22.02%
Owned by Institutions (%) n/a
Float 52.19M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 299.97
PB Ratio -13.18
P/TBV Ratio n/a
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings -18.56
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 0.01

Current Ratio 0.01
Quick Ratio 0.00
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -8.57

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) -524.03%
Return on Invested Capital (ROIC) n/a
Return on Capital Employed (ROCE) 65.06%
Weighted Average Cost of Capital (WACC) 12.89%
Revenue Per Employee n/a
Profits Per Employee n/a
Employee Count n/a
Asset Turnover 0.57
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -57.95% in the last 52 weeks. The beta is 1.62, so TSXV:ARCH's price volatility has been higher than the market average.

Beta (5Y) 1.62
52-Week Price Change -57.95%
50-Day Moving Average 1.04
200-Day Moving Average 1.36
Relative Strength Index (RSI) 32.05
Average Volume (20 Days) 39,481

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, TSXV:ARCH had revenue of CAD 158,079 and -2.70 million in losses. Loss per share was -0.04.

Revenue 158,079
Gross Profit -450,368
Operating Income -2.34M
Pretax Income -2.70M
Net Income -2.70M
EBITDA n/a
EBIT -2.34M
Loss Per Share -0.04
Full Income Statement

Balance Sheet

The company has 4,163 in cash and 2.63 million in debt, with a net cash position of -2.63 million.

Cash & Cash Equivalents 4,163
Total Debt 2.63M
Net Cash -2.63M
Net Cash Per Share n/a
Equity (Book Value) -3.60M
Book Value Per Share -0.05
Working Capital -3.60M
Full Balance Sheet

Cash Flow

Operating Cash Flow -1.53M
Capital Expenditures n/a
Free Cash Flow n/a
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross Margin -284.90%
Operating Margin -1,481.29%
Pretax Margin -1,705.36%
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

TSXV:ARCH does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -2.96%
Shareholder Yield -2.96%
Earnings Yield -5.69%
FCF Yield n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

TSXV:ARCH has an Altman Z-Score of -2419.03 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -2419.03
Piotroski F-Score 1